Skip to content

SRZN

Surrozen, Inc./DE

NASDAQ · Healthcare · Biotechnology · US

$23.84
+1.71%
Ask drillr

Forward multiples

Based on analyst estimates

P/E forward
—
P/E 2026E
—
P/E 2027E
—
P/E 2028E
—
P/S forward
84.27x

Trailing multiples

Trailing twelve months

P/E TTM
—
PEG TTM
—
Price / book
-1.28x
Price / sales
24.34x
Price / cash flow
-8.06x

Enterprise value

Enterprise value
$184.5M
EV / sales
16.03x
EV / EBITDA
-0.56x
EV / EBIT
-4.16x
Market cap
$280.2M

Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026